ClinicalTrials.gg
RecruitingNCT07368842Updated Feb 13, 2026

Scalp Hair Metabolomics in Severe Obesity

An observational study in Obesity & Overweight, Hair Loss and Metabolomics, sponsored by Singapore General Hospital. Recruiting at 1 site in Singapore. Open to participants aged 21 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-13.

Sponsored by Singapore General Hospital · Observational

How we know

From the registry’s dates

  • Started Feb 2026; still recruiting 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
60
Ages
21 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 83 studies in Obesity with a site in Singapore — 17 open to participants now, 25 under way, 1 of them phase 3. Obesity · Singapore.

Planned enrollment
11th of 15
60 · median 200
Started
2026
with 8 others
Observational
15 of 83
3 open now
Primary completion
2028-02
later than 20 of 24 live
Registered
74th of 83
by date
Lead sponsor
4 of 83
Singapore General Hospital

Among the 83 studies in Obesity with a site in Singapore, this one is the 11th largest by planned enrollment of the 15 observational ones that give a count, is one of 9 that started in 2026, is one of 15 observational ones, reaches primary completion later than 20 of the 24 other live ones, and was the 74th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

17 of the 83 studies in Obesity with a site in Singapore are open now. Recruiting first, the newest first:

11 more — sign in →

All 17 open studies →

A study can be open while its sites in Singapore have not opened yet or have stopped. Only those recruiting at a site in Singapore →

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 21 Years to 70 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 83 studies in Obesity with a site in Singapore, or all of them as a file.
02

Study summary

The purpose of this research study is to investigate how body weight and weight-loss surgery affect the natural chemicals found in scalp hair over time. We will also find out how common and severe hair thinning/hair loss and muscle loss are in the first 6 months after bariatric surgery.

Read the detailed description

The investigators will recruit 30 subjects with severe obesity scheduled for bariatric surgery and 30 healthy-weight controls.

Following written informed consent, the investigators will collect the study subject's medical information, conduct a dietary and quality-of-life survey, take body measurements, obtain scalp photos, perform a hair-pull test, collect a hair sample, and conduct muscle strength testing. Controls will be assessed only at baseline. Those with severe obesity will return at 4 ± 2 weeks, 12 ± 4 weeks, and 26 ± 4 weeks following bariatric surgery to repeat the study procedures.

03

Conditions studied

  • Obesity & Overweight
  • Hair Loss
  • Metabolomics
  • Bariatric Surgery

Keywords

  • obesity
  • hair loss
  • metabolomics
  • bariatric surgery
04

Who can participate

Ages eligible
21 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Subjects with severe obesity will be recruited from the Singapore General Hospital's obesity clinic, while controls will be healthy volunteers.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

All subjects:

  1. Age 21-70 years
  2. Ability to provide

Healthy weight controls:

  1. of 18.5-24.9 kg/m2
  2. No chronic disease
  3. No long-term medications

Severe obesity:

  1. BMI of > 32.5 kg/m2
  2. Scheduled to undergo bariatric surgery

Exclusion criteria

Exclusion Criteria:

  1. Pregnancy
  2. Any factors likely to limit adherence to study protocol
  3. Any history of or scarring alopecia (eg. alopecia areata, discoid lupus, lichen planopilaris)
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
60 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • Healthy controls

    Healthy controls with normal weight

  • Severe obestiy

    Participants with Severe obesity

06

What researchers measure

Primary outcomes

  1. Amino acid concentration

    Post-surgery changes in scalp hair amino acid concentration following bariatric surgery

    Time frame: From enrollment to the end of study duration at 6 months

Secondary outcomes

  1. Severity of hair loss

    The severity of hair loss is measured by quantifying the number of hairs lost during the hair pull test

    Time frame: From the time of enrolment until the end of the study at 6 months

  2. Scalp hair amino acid concentration (between groups)

    Differences in scalp hair amino acid concentration between controls and those with severe obesity

    Time frame: At the time of enrollment

  3. Grip strength

    The post-surgery changes in grip strength measured using handgrip dynamometer

    Time frame: From enrollment until the end of the study at 6 months

  4. Sit to stand speed

    Time taken to complete sit to stand test after bariatric surgery

    Time frame: From enrollment until study completion at 6 months

  5. Hair-specific Skindex-29 score

    Hair-specific Skindex-29 quality of life questionnaire score after bariatric surgery. scores ranging from 0 (no effect) to 100 (effect always experienced)

    Time frame: From enrollment until study completion at 6 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — All IPD that underlie results in a publication

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Feb 2028, 24 months after the start.

Of 796 non-industry observational studies under Obesity, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 106. This study's planned 24 months is below that.

Counting every sponsor, half of 842 studies reached it within 39 months; a quarter within 17 and three quarters within 96.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 20, 2026
First posted
Jan 27, 2026
StartActual
Feb 7, 2026
Primary completionEst.
Feb 2028
CompletionEst.
Feb 2028
Last update
Feb 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07368842
Responsible party
Sponsor
First posted
Jan 27, 2026
Start date
Feb 7, 2026
Primary completion
Feb 2028 (estimated)
Completion
Feb 2028 (estimated)
Last update
Feb 13, 2026

Study contacts

Hong Chang Tan, MD PhD
Contact
tan.hong.chang@singhealth.com.sg
+65 63214658
Hong Chang Tan
principal investigator · Singapore General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion